header logo image


Page 262«..1020..261262263264..270280..»

Wolf Administration Awards $1.3 Million to Fund Research to Grow PA Agriculture Industry – Governor Tom Wolf

January 31st, 2021 2:51 am

Harrisburg, PA - Agriculture Secretary Russell Redding today announced grants totaling $1.287 million to eight organizations for research on issues critical to sustaining and growing Pennsylvanias agriculture industry. Grant recipients include Pennsylvania State University, Temple University, University of Pennsylvania School of Veterinary Medicine, American Mushroom Institute, Baarda Farms, Coexist Build, Pasa Sustainable Agriculture and Team Ag, Inc.

Meeting the challenges of feeding a growing population amid rapid changes in climate, technology and animal and plant diseases demands investment in research and development, said Redding. These investments hold the promise and potential to spur the innovation we need to increase productivity; advance human and animal medicine; and support cleaner water, healthier soil and a safer food supply.

The grants, awarded by the Pennsylvania Department of Agriculture, focus on a broad range of research topics including detecting COVID-19 exposure in livestock, increasing farm productivity and profits, protecting pollinators, safely controlling Spotted Lanternfly and other invasive species and improving soil and water quality and sustainability through regenerative farming.

This funding supplements $900,000 in agricultural research support through the departments budget to Rodale Institute, the Penn State University Center for Agricultural Law, Penn State Extension, and the Centers for Beef, Dairy, Poultry and Livestock Excellence.

Following is a list of 27 grantees, amounts awarded and project titles:

MEDIA CONTACT: Shannon Powers - 717.603.2056, shpowers@pa.gov

# # #

Originally posted here:
Wolf Administration Awards $1.3 Million to Fund Research to Grow PA Agriculture Industry - Governor Tom Wolf

Read More...

Honor the Veterinary Heroes In Your Animal’s Life – PRNewswire – PRNewswire

January 31st, 2021 2:51 am

American Humane, the country's first national humane organization, recognizes the hard work these professionals put in day-in and day-out in the name of helping animals, and is pleased to announce that nominations are now open for the eighth annual American Humane Hero Veterinarian and Hero Veterinary Nurse Awards, presented by Zoetis Petcare (a U.S. business unit of Zoetis). Pet owners and animal lovers alike are invited to visit http://www.herovetawards.org between now and March 24 to nominate their favorite veterinary professionals dedicated to the betterment of the health and welfare of animals and the promotion of the people-animal bond. The winning veterinarian and veterinary nurse will be featured in the 11th annual American Humane Hero Dog Awards broadcast this fall, which will air nationwide as a two-hour special on Hallmark Channel.

These awards are not limited to companion animal veterinarians. Professionals from all fields of veterinary medicine are eligible for entry including, but not limited to those who work in research, emergency services, shelters, and those who work with large and exotic animals. The five finalists in the American Hero Veterinarian and American Hero Veterinary Nurse categories will be selected by a special blue-ribbon panel of judges consisting of veterinary professionals, animal care professionals and celebrities. Beginning June 10, the American public will be invited to vote online for their favorite veterinarian and veterinary nurse.

"Zoetis is honored to support America's veterinary community, and the American Humane Hero Veterinarian and Hero Veterinary Nurse Awards are our way of thanking these devoted individuals," said Tara Bidgood, DVM, PhD, DACVCP, executive director, Zoetis Petcare Veterinary Professional Services & Medical Affairs. "Veterinarians and veterinary nurses are leading the effort to keep America's animals happy and healthy, and they deserve recognition from a grateful nation."

"The world's animals depend on veterinarians and veterinary nurses, and we thank Zoetis Petcare, the exclusive sponsor of the Hero Veterinarian and Hero Veterinary Nurse Awards, for helping recognize their achievements in saving lives, conducting groundbreaking research, and working on the front lines of animal welfare," said American Humane President and CEO Dr. Robin Ganzert. "To us, all vets and vet nurses are heroes and these awards help us shine a bright spotlight on the best of the best."

Key dates for the 2021 American Humane Hero Veterinarian and Hero Veterinary Nurse Awards contest are:

Nominations Period:

Jan. 27 March 24

Public Voting Round:

June 10 July 29

Hero Dog Awards broadcast:

Coming this fall

*All rounds open and close at noon Pacific Time

To nominate a veterinarian or veterinary nurse between now and March 24, and for complete contest rules, please visit http://www.herovetawards.org. To nominate a Hero Dog in your life for the 2021 American Humane Hero Dog Awards, please visit http://www.herodogawards.org between now and March 2.

About American HumaneAmerican Humane is the country's first national humane organization. For more information please visit http://www.americanhumane.org, and please follow us on Facebook and Twitter.

About ZoetisZoetisis the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2019, the company generated annual revenue of $6.3 billion with approximately 10,600 employees. For more information, visit http://www.zoetis.com.

SOURCE American Humane

http://www.americanhumane.org

See original here:
Honor the Veterinary Heroes In Your Animal's Life - PRNewswire - PRNewswire

Read More...

MSU veterinary imaging research aims to help both man and his best friend – The Reflector online

January 31st, 2021 2:51 am

Mississippi State University's College of Veterinary Medicine is working to advance early disease detection in animals through their ground-breaking research in imaging technologies.

According to Dr. Alison Lee, doctor of veterinary medicine and assistant professor at MSU, the Department of Veterinary Medicine is using imaging technology such as CT and MRI machines to detect issues like brain tumors and inflammatory and infectious diseases in an animal's brain.

Lee said this research is conducted at an imaging center on Stark Road. Researchers are primarily using the MRI machine to focus on a brain tumor study.

"The MRI allows us to see central nervous tissuethe brain and the spinal cordmuch better than any other imaging technologies let us see it. It can tell us when there is anything abnormal in the brain," Lee said.

Dr. Andy Shores, clinical professor and CVM chief of neurosurgery and neurology, said this research is profound because brain tumors affect humans and animals in very similar ways, leading to advancement for the treatment of both groups.

Shores said the National Institute of Health has provided funding for MSU's researchers to look at novel ways to treat brain tumors, specifically glioblastoma, in both humans and animals.

"The dog is the model for the human disease because there are so many similarities with the type of tumor and the way it affects them," Shores said.

The neurosurgery neurology group that is focusing on imaging technologies is not merely performing research but instead applying it to real-life diagnosis and treatments.

"A lot of what we do is not really research but clinical activity," Shores said. "We incorporate what we are able to do with the patients and further the advancement of treatment for certain diseases."

According to Shores, he takes dogs who have brain tumors and uses the MRI to diagnose and plan for a surgical removal of the brain tumor. The dogs receive an injection of a modified virus designed to attack only tumor cells.

Shores then performs follow-up routine exams and imaging to check on the dog. Additionally, he puts them on another drug which helps to uncover the tumor and attack it.

Lee helps Shores assess the MRI images and decide which tumor is likely. She said they can use ultrasound imaging technology to help further localize the tumor during a surgery.

Imaging technology is helpful to use not only during surgery but also during follow-up treatment. Additionally, Lee helps Shores use cross-sectional imaging during the post-operative stage.

Lee is passionate about imaging technologies because brain tumors are devastating in both species. She said they cause behavioral issues and affect everything from an animal's ability to eat and drink to their ability to urinate.

"The brain is a difficult area to treat because we do not have a great understanding of exactly how it works and it is also covered by the skull, so it is a difficult area to operate on," Lee said. "All of what we are doing research-wise is going to help us better treat these animals and lead to longer survival times for both people and animals."

Bailey Haller, a senior biological sciences major from Gulfport, said MSU's research is extremely important for not just the veterinary medical field but the medical field as a whole.

"Mississippi State is finding ways to help animals that previously would not have been possible," Haller said. "They are also developing equipment and research that will be further explored for human use."

Haller decided to be pre-vet because she loves helping animals and learning how they function. She said she is honored to be a part of the program and hopes to work on research like this in the future.

Chief of Neurosurgery and Neurology Shores believes research like this is important because most people view their animals as companions, and that has made it increasingly important to make sure animals can maintain their health.

"Animals have evolved from being a pet around the house to being actual companions, family members and emotional support," Shores said. "Being able to look at those kinds of diseases and further treatment is a benefit to the animal and the human population because of their emotional attachment to their animals."

Lee hopes people are aware MSU has this technology and that this type of technology is not everywhere. She said if anyone has concerns about their pet, MSU's Animal Health Center is a wonderful place to visit.

"We can certainly help them get diagnoses and figure out the next best step for treatment," Lee said. "We are very lucky here to be able to offer this type of technology to clients."

Read more:
MSU veterinary imaging research aims to help both man and his best friend - The Reflector online

Read More...

Presentation Highlights Oncology Research Success | Purdue University College of Veterinary Medicine – Purdue Veterinary News

January 31st, 2021 2:51 am

Tuesday, January 26, 2021

Distinguished Professor of Comparative Oncology and Dolores L. McCall Professor of Comparative Oncology Deborah Knapp recently marked a milestone in her career. As an endowed professor, Purdue University requires Dr. Knapp undergo a review by her department every five years with the latest review completed last month. Dr. Knapp was first named the Dolores L. McCall Professor of Comparative Oncology in 2006 and has held the title ever since. As part of the review, Dr. Knapp was asked to present a seminar highlighting some of her research teams success.

The seminar entitled, Cancer Prevention in Dogs: Strategies That Can Be Implemented Now to Improve Outcomes, was presented virtually December 11, 2020. After an introduction by Dr. Catharine Scott-Moncrieff, head of the PVM Department of Veterinary Clinical Sciences, Dr. Knapp began her lecture by describing the current state of cancer cases in the United States. Last year, there were 1.7 million new cases of human cancer reported with 600,000 of these resulting in death. As for dogs, approximately 4 million cases were expected in 2020 with the total number of deaths unknown. Dr. Knapps team has tasked themselves with looking at ways to improve the outcome for humans and dogs.

In describing a key to improving the outcome for both, Dr. Knapp explained that certain forms of naturally-occurring cancer in dogs are very closely related to cancers in humans, allowing treatment methods to be studied interchangeably. In addition to defining cancer by the organ in which it originates (i.e. breast cancer), researchers have found that in many cases they can better define the cancer by its mutations and molecular makeup of the cancer. For instance, a subset of bladder cancer in dogs may be more closely related to colon cancer in people.

Dr. Knapp described that one way to improve cancer outcomes in humans and dogs is to improve the use of current drugs such as Cyclooxygenase (Cox) Inhibitors, also known as Non-Steroidal Anti-Inflammatory Drugs. These drugs have anti-cancer properties and are a good example of drugs that can be repurposed. Additionally, new drugs, such as immunotherapies, are currently being studied. The Purdue University College of Veterinary Medicine has recently received a research grant to improve knowledge of these methods. Another area that has the potential to make a big difference in cancer outcomes for humans and dogs is individualized care.

The primary focus of improvement described in the lecture is prevention. Cancer prevention comes in three forms. Primary cancer prevention is preventing the entire cancer development, such as not smoking to avoid lung cancer. Secondary cancer prevention is the detection of precancerous symptoms with testing such as mammograms and colonoscopies and treating them before they become aggressive cancers. Tertiary cancer prevention is the treatment of cancer once it is diagnosed to prevent morbidity and mortality.

Dr. Knapp focused on prevention in regard to bladder cancer, which most of the time is known as high grade invasive urothelial carcinoma, transitional cell carcinoma, aggressive bladder cancer, or in humans is called muscle invasive bladder cancer all essentially the same disease. Dr. Knapp said primary cancer prevention for dogs includes limiting risk factors such as the use of lawn care chemicals; obesity; the use of old generation flea, tick, and mange dips; and exposure to second-hand smoke. Emerging data now suggest that exposure to smoking could be important to bladder cancer in dogs. On the other hand, feeding vegetables to dogs can reduce the risk of cancer. There is now evidence to suggest spayed and neutered dogs are more at risk for cancer than dogs that are not spayed or neutered. Dr. Knapp certainly does not recommend ending the practice of spaying and neutering entirely, but said the optimal time for surgery requires further study, and this raises the question of whether waiting until the dog is a year old should be considered. More studies are needed to answer this question.

Secondary cancer prevention of bladder cancer can come in the form of early detection of precancerous lesions such as dysplasia and carcinoma in situ. In this stage, the cancer is less advanced and should be easier for the drugs to treat. Additionally, the immune system should be in a more active state to combat the cancer. This prevention strategy was tested by Dr. Knapp and her team in an early detection, early intervention study in which Scottish Terriers, a high-risk breed for bladder cancer, were studied. The study was completed in collaboration with the Scottish Terrier Club of America, which provided funding. The dogs were examined every six months for three years. Preliminary study results show that bladder cancer can be detected early, and early detection does improve the outlook for the dogs. Further evaluation is currently underway by Dr. Knapp and her study collaborators.

There are several key strategies that can be implemented now to improve cancer outcomes. Avoiding factors that increase the bladder cancer risk is important. Early detection and intervention are emerging as vital to improving the outcome for dogs with bladder cancer.

Dr. Knapp earned her DVM degree at Auburn University and in 1985 came to Purdue where she completed her residency and earned a masters degree in 1988. She then became board certified by the American College of Veterinary Internal Medicine (Oncology). She was named a Distinguished Professor of Comparative Oncology by the university in 2020. Dr. Knapp leads the Purdue Comparative Oncology Program and is regarded as the leading expert in the field of naturally occurring bladder cancer in dogs. Her research has established bladder cancer in dogs as the most relevant animal model for invasive bladder cancer in humans. She is the author of more than 100 peer-reviewed journal articles related to the subject.

Writer(s): Jonathan Martz, PVM Communications Intern, and Allison Carey | pvmnews@purdue.edu

Continued here:
Presentation Highlights Oncology Research Success | Purdue University College of Veterinary Medicine - Purdue Veterinary News

Read More...

On the road with the traveling veterinary nurse, Lucy Taylor – Vet Candy

January 31st, 2021 2:51 am

Most veterinary nurses finish school and find a clinic to work in for the rest of their lives. Although they may travel for pleasure, their work is relatively stationary, so customers know where to find the high quality vet care they need.

At first, Lucy thought she would be following a similar path, but a school trip abroad changed everything for her. She took an Erasmus trip to Estonia, and volunteered at an animal shelter there. The trip changed her. She took another trip, this time with the focus of conservation in South Africa the following year, and knew what she wanted to do with her life.

Lucy made a bold move after veterinary school, and became a traveling locum nurse. She has since been to Spain, Sardinia, and Morocco for her work. While she is in these locations, she often volunteers with organizations such as Vets Beyond Borders, so she can help make a difference in the lives of animals in need.

A typical volunteer day may involve working closely with vets to examine, anesthetize, and spay or neuter a long string of dogs as quickly as possible. Not only are the animals spayed or neutered, but other procedures that may benefit the animal are done at the same time while they are under. This could mean extractions to remove decaying teeth, or enucleations.

Sometimes the animal is too unhealthy for surgery, at which point they would call and recommend to the shelter or who ever they are currently helping that the animal not undergo surgery. Other complications, such as retained testicles, can also make it harder to do the surgery.

Often, the veterinary team ends up missing lunch or working late into the night, in order to help as many animals as possible. While it is difficult work, they are happy to do it because that means one more animal is getting the help it needs.

Lucy is passionate about her job, and loves every moment of helping animals while she travels the world. While she knows this job is the perfect one for her without a doubt, if she hadnt become a vet she did have other aspirations to follow.

Her original childhood dream was to become a zookeeper, which she might have pursued if veterinary school had not have been an option. Her other choice would be as an entertainer. In fact, she still sometimes plays an Elf at Christmas time in Lapland, Finland!

When shes not an Elf, she still finds the ability to entertain but also educate through a podcast about becoming a traveling veterinary nurse she does with co-host Amber LaRock. In it they talk about traveling veterinary medicine, and the unique aspects of trying to help animals while on the road.

Lucy enjoys every minute of her life as a traveling veterinary nurse. She has helped save thousands of needy dogs through her efforts in far away countries, and has also been an inspiration for veterinary students who dream of helping animals, but also traveling too.

Here is the original post:
On the road with the traveling veterinary nurse, Lucy Taylor - Vet Candy

Read More...

IMMS and MSU veterinarians work to save dolphin – WXXV News 25

January 31st, 2021 2:51 am

So far, so good but researchers and care takers at the Institute for Marine Mammal Studies, as well as workers with Mississippi State Universitys College of Veterinary Medicine have their hands full caring for a young male dolphin they rescued Sunday.

This young dolphin fell into the right hands and has a second lease on life thanks to good Samaritans who called the IMMS Sunday morning to report the young juvenile male dolphin appeared to be struggling in the shallow waters of the Mississippi Sound in Gulfport.

Once here at the Gulfport facility, workers with the IMMS and MSUs College of Veterinary Medicine did blood work and diagnostics to assess the state of his condition. His care spilled over in to Monday. Clinical Instructor and Veterinarian at MSU College of Veterinary Medicine Christa Barrett said, Hes still not strong enough to keep himself up, so we have had people in the water here 24-7, and staff here 24-7 with him, to make sure he is able to breathe. Right now, we have Theresa in the water to make sure he is able to breathe. We gave him a combination of some milk, vitamins and things like that to help keep up with his nutritional status.

His mother was nowhere to be found. He does not appear to yet be weaned, but fortunately for this little guy, hes now in capable hands and its not sink or swim time just yet. Hes still in very critical condition, but were doing everything we can. We also have a great faculty staff at Mississippi State University in case we need any specialists to weigh in on the case as well.

As in this case, the IMMS asks anyone who sees a stranded dolphin or sea turtle to contact them as soon as possible. IMMS Director Dr. Moby Solangi said, Stranding season is coming up. Its very important if people see a sick or injured dolphin to call IMMS at 888-SOS-DOLPHIN.

In the meantime, this dolphin will continue to receive critical and supportive care to get him to swim on his own again and hopefully be released back into the Mississippi Sound.

More here:
IMMS and MSU veterinarians work to save dolphin - WXXV News 25

Read More...

This wildlife vet tracks deadly microbes in the African jungle. Now, he’s on the trail of COVID-19 – Science Magazine

January 31st, 2021 2:51 am

Fabian Leendertz has spent decades studying how diseases flow between humans and wildlife. Here, he and colleagues hunt for bats in Ivory Coast.

By Kai KupferschmidtJan. 28, 2021 , 12:05 PM

TA NATIONAL PARK IN IVORY COASTThe message arrived as Fabian Leendertz was watching what he calls breakfast TV: a troop of black-and-white colobus monkeys leaping acrobatically through the trees that tower above the remote field camp here near the Liberian border. A colleague had received word that the carcass of a duiker, a kind of antelope, had been spotted in the rainforest some 10 kilometers away.

The notification launched Leendertz, a wildlife veterinarian at the Robert Koch Institute, into a race against time. The jungle is a hungry place, and Leendertz and his team needed to hike to the carcass before it was hauled away by a leopard or consumed by smaller animals. If the researchers beat the scavengers, they could collect tissue and other materialsincluding maggots feeding on the carrionthat could help answer a fundamental question: What do animals in the jungle die of?

Leendertz and his colleagues have been chasing answers here in the Ta forest for the past 20 years, studying hundreds of carcasses and sampling living animals in one of the only long-term studies of its kind. Theyve found that poachers and predators arent the only deadly threat lurking in the rainforestinfectious diseases are a big killer, too.

A discovery that leprosy can infect wild chimpanzees broke new ground.

The findings have implications for both saving endangered animals, especially apes, and protecting human health. Leendertzs work has revealed, for example, that chimpanzees can die from common cold viruses introduced by humans, prompting scientists, conservation groups, and ecotourism firms to impose new requirements on people visiting the apes. His team has also discovered a previously unknown variant of anthrax that appears to pose a major threat to wildlife. And he and colleagues in Guinea-Bissau recently found that wild chimpanzees suffer from leprosy, suggesting apes might be a previously undetected reservoir of that disfiguring disease, which could spill over into human populations. Fabians work has really changed how we view biosafety and biosecurity around great apes in the wild, says disease ecologist Tony Goldberg of the University of Wisconsin, Madison.

Now, the 48-year-old Leendertz, who once investigated the animal origins of an Ebola outbreak in West Africa, has been asked to help to solve one of the great disease mysteries of the early 21st century: the origins of SARS-CoV-2, the coronavirus that originated in bats and has killed more than 2 million people worldwide. In November 2020, the World Health Organization (WHO) named him to a 10-person team that is examining how the COVID-19 pandemic emerged. At the same time, Leendertz is worrying about how the coronavirus might affect great apes if it spreads to those vulnerable species.

Just 30 minutesafter the message arrived, Leendertz and two other veterinarians, Penelope Carlier and Bernard Ngbocho Nguessan, set off to find the carcass. After a kilometre or so, they passed a group of sooty mangabey monkeys lounging on logs. The animals, even a mother hugging a baby to her belly, appeared undisturbed by the hikers. That is because the monkeys had been habituated; researchers followed them for years until they grew used to humans.

In 1979, primatologists Christophe Boesch and Hedwige Boesch-Achermann came to the forest, one of the last large swaths of rainforest in West Africa, to study chimpanzee behavior. Over years, they habituated chimps, mangabeys, and several other kinds of monkeys, and began documenting their lives. But then, in 1994, the chimpanzees started to die. Eight of 43 study animals turned up dead; four more disappeared.

Before necropsying wild animals, Fabian Leendertz and Kouadio Leonce don protective gear.

The researchers hauled one chimps body back to their camps sturdy dining table for dissection. They wore gloves, but no gowns or masks, and 1 week later one woman fell ill. She recovered, but scientists isolated a virus from her blood. It was a new species of Ebola, a group of viruses already known from human outbreaks elsewhere in Africa, and the dead chimp carried it, too. The discovery of what became known as Ta forest Ebola marked the first time an Ebola outbreak had been documented in nature.

The experience was a wake-up call from both a safety and a scientific perspective, says Boesch, who retired as director of the Max Planck Institute for Evolutionary Anthropology in 2019. In retrospect it is clear that we ran a risk; we were not prepared at all, we had no equipment. And it made the researchers realize that infectious diseases could be playing a larger role in wildlife mortality than they realized. We cannot go on like this, Boesch recalls thinking. They needed a trained veterinarian, and in 2001 Leendertz got the job.

It was the kind of position he had long coveted. Growing up in Krefeld, Germany, Leendertz had bred mice and toads and spent a lot of time at the local zoo. (The director was a friend of his parents.) At university, he began to study biology but grew frustrated. It was just way too much biochemistry, he recalls, including countless hours in the laboratory running polymerase chain reactions (PCRs) to amplify snippets of DNA. All these PCRs were so far removed from working with actual animals, he says, so he switched to veterinary medicine.

In 1999, after completing his undergraduate studies and working in Namibia for a few months, Leendertz reached out to Boesch, asking whether he could join the Ta project. The reply was yesif Leendertz found an academic laboratory that would help support his graduate studies.

That wasnt easy. But Beatrice Hahn, a virologist at the University of Pennsylvania, had just published work showing HIV, the virus that causes AIDS in humans, had come from chimpanzees. The discovery ignited scientific interest in zoonoses, diseases that jump from animals to humans. That was kind of the first big aha! moment about zoonotic disease, Goldberg says. It helped Leendertz find a home at the Robert Koch Institute and ensured that, from the start, he would focus on both veterinary and human medicine.

Researchers draw blood from a dog in a village in Ivory Coast as part of their efforts understand how pathogens move among species.

Starting in 2001, Leendertz spent 14 months at Ta, following chimpanzees through the forest, collecting feces, and conducting necropsies. That was the real starting point for my work, he says. The conditions didnt bother him. He was content to be outdoors and largely cut off from the world, able to send and receive emails just once a week though a satellite connection. Leendertz didnt see images of the planes hitting New York Citys twin towers in 2001 until the year after the attack, after he emerged from his sojourn in the forest.

After a long march,the team found what was left of the dead duiker, surrounded by buzzing flies. Leendertz and Carlier suited up: masks, body suits, face shields, layers of gloves. They filled a bucket of bleach to disinfect equipment. Then they began cutting snippets of tissue and collecting blood, even grabbing a few maggots, which would be liquefied and analyzed for any pathogens they carried.

Moving deliberately around the forest in their gleaming white suits, the researchers looked like investigators at a crime scene. They were, in a way, with the added complication that the killer might still be lurking nearby. Leendertz has been following one suspect in particular since his first stint in the Ta forest. He was watching a group of chimpanzees when an alpha male named Leo suddenly vomited. Then, He climbed on this low branch, toppled over, and died, Leendertz recalls. I was stunned.

The killer, Leendertz and his group reported inNaturein 2004, was anthrax. It later became clear, however, that the cause was not the usual anthrax bacterium, but an unusual variant ofBacillus cereus, a soil bacterium that is usually benign. But this variant had acquired two circles of DNA, called plasmids, that had turned it into a formidable killer.

Subsequent work showed the bacterium was attacking other Ta forest mammals, too, including monkeys, mongooses, and porcupines. In 2017, the team published evidencegathered from bones, carcasses, and even fliesthat it appeared to be associated with 38% of 279 deaths the team had investigated from 1996 to 2015. The work was a reminder, Leendertz says, that we understand very little about what animals really die of in an environment like this.

Most worrying, theNaturepaper presented simulations showing anthrax could help wipe out the Ta forests chimpanzees within 150 years. And anthrax is not the only disease threatening the chimps, other work by Leendertzs team has shown. On top of all of the deforestation, the poaching they are just getting bashed by these infectious diseases, says primatologist Kimberley Hockings of the University of Exeter.

Some of those deadly diseases come from humans, Leendertz and colleagues reported in 2008 inCurrent Biology. After investigating five respiratory disease outbreaks that had struck Ta chimpanzees between 1999 and 2006, killing at least 15 individuals, the researchers concluded they were linked to two viruses that commonly cause mild disease in humans: human respiratory syncytial virus and human metapneumovirus. Our results suggest that the close approach of humans to apes, which is central to both research and tourism programs, represents a serious threat to wild apes, they wrote.

In Ivory Coast, veterinarian Fabian Leendertz traps bats to test for Ebola virus.

The idea was not new. Jane Goodall, the prominent primatologist, had described a pneumonia outbreak that killed several chimpanzees; researchers believed it was caused by a human-introduced pathogen. But theCurrent Biologystudy, and a similar viral outbreak documented in Tanzania, highlighted the threat of what Goldberg calls reverse zoonoses. Its a world of viruses that are crossing species in every direction, he says. And whenever that happens, it can cause devastating losses. (Goldberg has shown that the most common human cold virus, rhinovirus C, caused a deadly 2013 outbreak among chimpanzees in Uganda.)

The 2008 study also presented a dilemma for primate researchers such as Boesch, who was one of the co-authors. It suggested that even as they studied and worked to protect apes, they might be killing them, too. So, to reduce the risk of future outbreaks, the Ta researchers imposed new restrictions: Incoming staff must quarantine at the camp for 5 days before going into the forest, and everyone must stay at least 7 meters from study animals as well as wear masks while observing. Leendertz, meanwhile, pushed hard for field sites and tourism firms elsewhere to adopt similar measures, co-authoring safety guidelines published in 2015.

Such efforts really opened peoples eyes [that we needed] to be a lot more careful, Hockings says. But, It was a very controversial thing before COVID, Goldberg adds. People were afraid that tourists would be angry if you tried to make them wear a mask, that the apes would be afraid of the masks and attack tourists that foreign governments would get less money from tourism.

Today, Leendertz says helping catalyze such practical, real-world change is among his proudest accomplishments. And he says the experience only underscored the value of long-term, multifaceted studies of wildlife mortality. The threat that infectious diseases pose to chimpanzees was long underestimated and hardly studied, he says. They were neglected for a long time.

DESPITE HIS LOVE of fieldwork, Leendertz is spending less time in the Ta forest these days, visiting just once or twice a year. When my feet are hurting because Im not used to the long distances anymore, and when I get up in the morning from that moldy mattress, I do think that time is over, he says. Still, he says, When I arrive it really is that feeling of coming home.

At the Robert Koch Institute, meanwhile, Leendertzs lab is busy with samples shipped by colleagues in the forest. Located in a brand-new building that also houses one of the worlds newest biosafety level four high-biosecurity labs, the lab uses state-of-the-art technologies to identify and characterize the pathogens found in the samples. Ironically, Leendertz notes, Im back to doing PCRs. Recently, for example, the samples collected from the dead duiker in 2019 were analyzed. The antelope was, as suspected, infected with anthrax.

A research team heads into Kanankru, Ivory Coast, to search for bats, which have been implicated in outbreaks of Ebola and other deadly diseases.

Such molecular sleuthing isnt just about identifying animal killers. Leendertz notes that, when paired with careful field observations, lab findings can yield important insights into protecting human health. In 2017, for instance, some Ta chimpanzees began to cough and display respiratory distress. Lab work showed the cause was monkeypox, a less deadly relative of smallpox that can move from primates to humans. In humans, monkeypox often announces itself through a skin rash, but Leendertzs work suggests coughing is an unusual symptom that health workers working in communities near primate populations should keep in mind.

More recently, Leendertzs team has discovered that leprosyanother disease with the potential to jump to humansaffects wild chimpanzees too. In 2017, Hockings, who studies chimpanzees in Guinea-Bissaus Cantanhez National Park, observed animals with lesions on their faces and hands. She shared her observations with Leendertz, and soon afterward he noticed similar lesions on Woodstock, a Ta chimpanzee. By analyzing fecal samples, the researchers confirmed the lesions were caused by leprosy, a disease never before seen in wild chimpanzees.

The discovery has highlighted how little is known aboutMycobacterium leprae, the bacterium that causes leprosy, says immunologist John Spencer of Colorado State University, Fort Collins. Researchers cant culture the microbe in the laboratory and, although they have found it circulating in armadillos and red squirrels, it hadnt been seen in apes. The chimp find suggests leprosy has other niches that it has adapted to, Spencer saysand adds one more pathogen to the growing roster of diseases that afflict both humans and other animals.

If Leendertz has builthis career on the dual concerns of human and chimpanzee health, then the emergence of SARS-CoV-2 has brought these two issues together with new urgency. The virus now rampaging through human populations is a potential threat to great apes as well, Leendertz and primatologist Tom Gillespie of Emory University warned in a letter published inNaturein March 2020. To reduce the risks, they asked governments to suspend ecotourism and researchers to reduce field research, and many complied.

Since then, gorillas at the San Diego Zoo have tested positive for SARS-CoV-2. They showed only mild symptoms, but that is not very reassuring, Gillespie says, because captive animals tend to be well fed and be less burdened with other infections. Its really hard to say from captive studies what we would see in the wild, he says.

Looking ahead, Leendertz says, The question is how to get back to a more normal situation for primate scientists. One concrete step could be to vaccinate researchers and people living around field sites like Ta, he suggests.

In the meantime, WHO has asked Leendertz to join its investigation into the origins of SARS-CoV-2. That appointment makes sense scientifically and politically, colleagues say. Leendertzs years of patient, intensive focus on understanding death in a single rainforest have given him a valuable perspective on how to investigate pathogens hopping from one species to another, as SARS-CoV-2 is believed to have done. And he represents the Robert Koch Institute, Germanys equivalent of the U.S. Centers for Disease Control and Prevention. I see the WHO mission as about 50% actual science and 50% building bridges with Chinese colleagues, Goldberg says. I think Fabian will do well on both fronts.

But Leendertz also knows from past experience with virus hunts that definitive answers can be hard to come by. In 2014, he led a team that traveled to Meliandou, Guinea, shortly after the start of an Ebola outbreak that ultimately killed some 1000 people. The researchers interviewed villagers, who told them about a hollow tree where the child who had been the first to get sick had played.

When the team visited the tree, they discovered it had burned (whether by accident or intention wasnt clear). On the blackened stump, they found traces of DNA left behind by bats that had apparently roosted in the tree. Had an encounter between the child and a bat sparked the outbreak? It was a plausible scenario, they concluded, but there would likely never be proof.

The chain of events that led to the COVID-19 pandemic is likely to be far more elusive. And the WHO investigation has gotten off to a bumpy start. When the team first tried to visit China earlier this month, officials barred several members from entering because of pandemic restrictions. Leendertz himself could not join the trip because of a family commitment. So, while his colleagues conducted Zoom meetings from the hotel rooms where they were quarantined after arriving in China, Leendertz joined from his home, where it was 2:30 a.m. It was another kind of breakfast TV, just not the episode he enjoys the most.

Read the rest here:
This wildlife vet tracks deadly microbes in the African jungle. Now, he's on the trail of COVID-19 - Science Magazine

Read More...

Police report associated with former LSU player’s 2020 arrest reveals alleged animal abuse – WBRZ

January 31st, 2021 2:51 am

BATON ROUGE Former LSU defensive end, Ray Parker, bonded out jail Thursday (September 10) after being arrested on-campus for battery of a dating partner. Records indicate that Parker's bond amount was $4,500.

According to a police report, he was arrested on LSU campus around 2:30 a.m., Wednesday for allegedly abusing his girlfriend and destroying personal items in her apartment, including an iPhone valued at $1,600.

Arrest records obtained by WBRZ say the two had been dating for about a year, but got into an argument shortly before the altercation, which led to Parker becoming enraged and destroying items around her apartment in addition to pushing her into a dresser, leaving a scrape on her hip.

Police say the woman's injuries and the damage to her apartment and belongings were consistent with her story, so Parker was arrested and booked on charges of battery of a dating partner and criminal damage to property.

Hours after the arrest, LSU head football Coach Ed Orgeron announced that Parker was cut from the team for violating its rules.

Later documents were obtained that shed additional light on the events surrounding Parker's arrest.

A police report dated as "filed" on September 17, 2020 says Parker's former girlfriend accused Parker of beating up their puppy, a pit bull named 'Kash.'

According to the report, she accused Parker of breaking one of the puppy's ribs and legs in addition to threatening her via text message, saying that Kash might be dead by the time she arrived at his apartment.

The girlfriend went on to tell detectives that due to a lack of funds necessary to cover Kash's medical expenses, she turned the puppy over to the LSU School of Veterinary Medicine. Police say they followed up with LSU SVM and found that the young pit bull's leg had to be amputated due to multiple breaks and fractures.

A roommate, according to the police report, also confirmed accusations against Parker in connection with the abuse of the puppy, saying they'd seen Parker kick Kash on multiple occasions.

The roommate said they would often hear the puppy crying and would tell Parker to "chill out."

Parker, 20 years old at the time, was in his second year with the Tigers after redshirting as a true freshman in 2019.

Read this article:
Police report associated with former LSU player's 2020 arrest reveals alleged animal abuse - WBRZ

Read More...

Using Dogs and DNA to Diagnose Diarrhea in Foals The Horse – TheHorse.com

January 31st, 2021 2:51 am

The pictures arent pretty, and the condition is serious. But what truly stinks about foal diarrhea is that in more than half the cases, veterinarians never identify the underlying cause. Yet, according to Nathan Slovis, DVM, Dipl. ACVIM, CHT, director of the McGee Center at Hagyard Equine Medical Institute, in Lexington, Kentucky, that scenario is changing. Developing technologiesand even the use of certified sniffer dogs that can identify Clostridium difficile in humansare making it faster and easier to diagnose whether the culprit is viral, bacterial, protozoal, or something else.

Twenty percent of foals will get some form of infectious diarrhea, Slovis said during his presentation at the 2020 American Association of Equine Practitioners Convention, held virtually. And because so many possible causes exist, veterinarians often find themselves treating symptoms without really knowing what theyre up against. Pathogens such as rotavirus, clostridium, and salmonella can proliferate in neonates with lethal speed. Fortunately, veterinarians can now use real-time polymerase chain reaction (PCR) testing to swiftly identify viruses, bacteria, and protozoa by amplifying fragments of genetic material in blood and fecal samples. Slovis explained that by recording how many cycles it takes to replicate the DNA to a trillion copies, the test also offers a way to quantify infectious loads.

For too long, veterinarians had to rely on what they could see under the microscope or what they could culture in a petri dish. Cultures are often misleading, because potentially harmful bacteria can be found everywhere, even in perfectly healthy horses. Real-time PCR has been a diagnostic game-changer in both human and veterinary medicine, he said.

Routinely treating foals with antibiotics has become controversial, Slovis acknowledged. Antibiotics are ineffective against viruses, and theres growing concern about antibiotic-resistant bacteria, including multidrug resistant strains of salmonella. Genetically engineered bacteria-eating viruses known as bacteriophages hold future promise for treating some of these antibiotic-resistant infections, but more research is needed.

Antibiotics do change the gastrointestinal (GI) tract microbiome, leaving researchers to wonder whether they simply make diarrhea worse. Nonetheless, Slovis generally favors giving sick foals a broad-spectrum antibiotic even when he suspects and confirms rotavirus.

Neonates are different than adults, he said. Bacteremia (bacteria in the bloodstream) occurs in 50% of foal diarrhea cases. Because endotoxins can be deadly, his strategy is to quell any primary or secondary bacterial infections before the foals body is overwhelmed.

Slovis also made a strong pitch for vaccinating pregnant mares against rotavirus and salmonella. A two-dose vaccine for Salmonella typhimurium and agona (conditional license in Kentucky) can be given to mares at nine and 10 months of gestation or to foals of unvaccinated mares during their first month of life. The rotavirus vaccine requires three doses administered at eight, nine, and 10 months of gestation.

Studies show the rotavirus vaccine:

Unfortunately, the currently available rotavirus vaccine only protects from the G3 strain, not the G14 strain thats becoming more common in Kentucky and elsewhere, Slovis said. He hopes a pharmaceutical company might be persuaded to work on a vaccine offering crossover protection between these two equine strains.

Rotavirus hits young foals hard and fast, with a one- to two-day incubation period. The virus invades the GI tract and impacts the production of lactase, which interferes with milk digestion, leading to diarrhea and painful bloating. Using PCR is the best way to diagnose it. Immunoassay tests can also be helpful, he noted, but they must be validated for horses, because human rotavirus antigen tests can provide false negatives in equines. Therapies include providing fluids, ulcer medication, pain relievers, and lactase to support digestion, reduce bloating, and calm the bowels.

Rotavirus shedding can continue for up to 10 days after the babys manure firms up, and the virus can persist in the environment for up to nine months, he cautioned. Bleach is not an effective disinfectant against the virus, whereas alcohol and hydrogen peroxide formulations are, he said.

Bacteria can also plague young foals, with C. difficile, C. perfringens, and Salmonella common culprits. Slovis warned that types A and C of C. perfringens are associated with fatal foal necrotizing enterocolitis (damage and death of cells in the small intestine and colon), so theres no time to waste. By the time a positive culture comes back from the lab, it could be too late. Again, he said PCR is the new gold standard for identifying bacterial loads, possibly providing results within hours.

Lateral flow enzyme immunoassay tests that screen for both antigens and toxins are also useful. Theyre quick and easy, but sometimes produce ambiguous results, such as indicating positive for antigens but negative for toxins.

We used to believe that if we didnt see that a test was positive for a C. difficile toxin, then it wasnt significant, Slovis said. Yet after studying many antigen-positive/toxin-negative foals (all of which had diarrhea, and all which responded to the antibiotic metronidazole), he found PCR tests confirmed more than three-quarters of them did have C. difficile infections.

Yet PCR isnt the only trending diagnostic development. Slovis noted that canines are being trained and certified to sniff out C. diff and other infections. These special technicians, however, are currently in short supply in human medicine.

Hygiene is hugely important in preventing or reducing foal diarrhea outbreaks. If barns are potentially infected, he suggests foaling mares outdoors until all stall surfaces, tack, and equipment have been thoroughly disinfected. Foaling kits should contain only single-use items and equipment that can be sterilized between uses. Slovis also recommended using disposable udder wipes to cleanse the mares udder and hindquarters before her baby nurses. A bath before or after foaling might also be in order. He also emphasized proper handwashing for those handling mares and foals. Soap and towels (preferably touchless), along with hand sanitizer, should be within easy reach and installed where they wont be contaminated, which means not just sitting on the counter next to the sink.

His recommendations also include:

Not every case of foal diarrhea is preventable. But faster, more accurate diagnostics reduce guesswork regarding treatment, leading to better outcomes for babies.

Read this article:
Using Dogs and DNA to Diagnose Diarrhea in Foals The Horse - TheHorse.com

Read More...

Pet Care Center of Apopka is your other family doctor that provides exceptional care from head to tail | – Apopka Chief

January 31st, 2021 2:51 am

New Clients: Get your pets first exam free. Pet Care Center of Apopka is located at 2807 North Rock springs Road, near Rock Springs Elementary. Pictured above are owners Dr. Kent Greer and wife Annie on their Apopka family farm.

More than 40 years ago Dr. Kent Greer, Hospital Director and founder of Pet Care Center of Apopka, graduated from University of Missouri.

Drawing on the example of his fathers practice, he opened his first veterinary hospital in 1985. Dr. Greer, a second-generation veterinarian, decided to build what was to become a new concept in veterinary hospitals for Central Florida. This facility offered in-house diagnostics with the very first IDEXX blood machines in the United States. Annie came on board as an animal behaviorist, and Annie and Dr. Greer married in 1996.

Dr. Greer is the senior doctor and oversees all aspects of his practice. Having over 40 years of surgical experience, including orthopedics and soft tissue and internal surgeries, hes a certified Veterinary Chiro-practitioner and has a profound interest in alternative medicine as a means to support conventional care. As such, he is one of the leaders in Central Florida of alternative therapies.

The skilled team at Pet Care Center of Apopka work to prevent and treat conditions as well as educate pet parents on all aspects of their pets health. To further extend their care, your pets first exam is free. This free first exam is a great time for them to get to know you and your pet, make preventive recommendations, and/or begin the path towards better health for your pet.

Sometimes, all your pet needs is a good look over with nutritional, behavioral, or exercise advice. Frequently, the staff at Pet Care Center of Apopka is referred to for second opinions. When a patient is experiencing ongoing health problems, they identify the cause and, in turn, make treatment recommendations. Your pet may be due for such things as vaccinations, a comprehensive veterinary examination that addresses the entirety of your pets well-being.

In 2003, Dr. Greer and his wife Annie saw a unique opportunity to expand their services. They created an exceptional, first-class pet resort, which is combined with their advanced medical services. They converted a family residence and added a $1.5-million state-ofthe-art boarding facility that retained the integrity of the beautiful six acres of woodland and grasslands on the property. Then they added a 35 x 24 ft swimming pool especially designed for your pet and their safety.

In these times of Covid, all precautions have been taken. With the space granted, the public is still able to wait inside and have face-to-face conversations with the doctor and staff. There is no waiting in the parking lot in your car. Deep cleaning is a given, and all staff and clients have felt safe. We are essential workers, and you, as clients are also deemed essential according to Orange County edict, stated Annie.

We are seeing an influx of new clients (eligible for a free exam) and many second opinions and certainly the case load of surgeries that are non-elective have increased exponentially.

In todays corporate takeover of veterinary medicine, experienced veterinarians capable of handling cruciate ligament surgeries, soft palate reconstruction and other serious conditions are simply not available, and the specialty practices are very often prohibitively expensive. Dr. Greer is valued for his years of surgical experience, and he is always happy to explain in length the procedure your dog may, or may not, need.

Pet Care Center of Apopka is now on Instagram and Face Book for ease of questions and information. Follow them, but most importantly, visit their website at centralfloridavets.com for the latest offers and information.

Pet Care Center of Apopka and Pet Resort of Apopka are conveniently located at 2807 North Rock Springs Rd, near Rock Springs Elementary. Open for business six days a week! Call 407-884-8924 to make an appointment or to get details regarding your free first time exam.

Advertisement

Excerpt from:
Pet Care Center of Apopka is your other family doctor that provides exceptional care from head to tail | - Apopka Chief

Read More...

Pet talk: Got milk? The ins and outs of dairy goat ownership – Marshall News Messenger

January 31st, 2021 2:51 am

For the more adventurous pet owner, there are many advantages to owning goats, including companionship, land management by grazing, and milk production. While companionship and grazing come naturally to these critters, potential owners interested in collecting dairy from their goats need to take into consideration additional factors to encourage lactation and ensure that their goats milk is safe for consumption.

Dr. Evelyn Mackay, a clinical assistant professor at the Texas A&M College of Veterinary Medicine & Biomedical Sciences, says that the production capacity of a dairy goat depends on their breed, management, and nutrition.

The most common dairy goat breeds are Nigerian dwarf goats, Alpines, Saanens, Nubians, LaManchas, and Toggenburgs; Nigerian dwarves are significantly smaller than the other breeds and may be preferred by hobby farmers who would like a smaller milk yield.

Since goats will only lactate after giving birth to a kid, the relationship between parent and offspring must also be taken into account. Depending on the goat and management conditions, dairy goats can produce milk for many months after giving birth.

If owners are letting the kids nurse, owners will have a smaller milk yield than if they weaned the kids and only milked the goat, Mackay said. Some full-sized, high-producing goats can produce over two gallons per day at some stages of lactation. A home dairy goat would likely produce less than a gallon per day, especially if she is nursing kids.

Regardless of the goats desired milk yield, Mackay recommends that owners allow for a dry period between milking a goat and it giving birth again.

In order to impregnate a dairy goat, owners may keep their own male goats for breeding or can rent one via a stud service.

Its easier to own a male goat, but they are smelly and sometimes poorly behaved, Mackay said. Some people will borrow or lease a male if they only have a few females to breed. Artificial insemination can be done but is expensive and is more labor- and time-intensive than in other species.

Typically, dairy goats should be milked, fed, and cared for twice daily. After a goat is milked, it is important that owners ensure the goat milk is safe for consumption.

Owners should absolutely pasteurize their milk, she said. Raw milk is not safe for human consumption and can transmit dangerous diseases to people, such as Q Fever, brucellosis, listeriosis, salmonellosis, and many others.

Although the benefits of owning a dairy goat are many, potential owners should be aware of the care requirements to keep their goat healthy and fit for milk production.

They require just as much attention as other livestock, and paying close attention to udder health and overall health of dairy goats is very important, Mackay said. They can get mastitis (inflammation or infection of the breast tissue) and other diseases related to pregnancy and lactation. Owners need to learn appropriate milking hygiene procedures and be prepared to seek veterinary attention for their dairy goats if they become ill.

Pet Talk is a service of the College of Veterinary Medicine & Biomedical Sciences, Texas A&M University. Stories can be viewed on the web at vetmed.tamu.edu/news/pet-talk. Suggestions for future topics may be directed to editor@cvm.tamu.edu.

View post:
Pet talk: Got milk? The ins and outs of dairy goat ownership - Marshall News Messenger

Read More...

Exploring MSU Tollgate virtually is the next best thing to being on the farm – WXYZ

January 31st, 2021 2:51 am

NOVI. MICH (WXYZ) MSU Tollgate provides non-formal learning for children, families, and adults, offering the unique opportunity to experience agriculture hands-on in an urban environment.

You and yours are invited to spend time exploring the MSU Tollgate barn and pastures virtually as you investigate veterinary science and animal medicine. You'll get to know an array of animals as you experience the care of our livestock up close and personal.

You can also explore the five freedoms, engage in STEM challenges, and learn about veterinary tools & technology. Interactive real time sessions with MSU Extension Animal Science educators, Tollgate Farm staff, and visiting vets complement investigations and activities. This is the next best thing to being on the farm! A list of upcoming events is posted below.

The cost is $40 first youth participant, $25 additional youth in family. To learn more, visit https://www.canr.msu.edu/tollgate/

MSU Tollgate Farm Summer Stewards Teen Leadership Programs ages 13-19 https://events.anr.msu.edu/tollgatestewardsteenleadershipprogram/ [events.anr.msu.edu]The Tollgate Camp Teen Steward (15-19 yrs) and Tollgate Steward-in-Training (13-14 yrs) positions are for teens interested in gaining experience working with campers in outdoor farm setting. This experience offers teens a chance for stewards to enrich, mentor, and lead campers while gaining valuable leadership and life skills. In a positive educational environment, teens experience the responsibilities associated with potential career paths before entering college.

MSU Tollgate Farm Summer Stewards Sustainability Leadership Institute ages 15-19 https://events.anr.msu.edu/2021MSUTollgateSSLI/ [events.anr.msu.edu]Scheduled for June 14-19, 2021, SSLI is a fun, adventurous six-day training and youth development summit incorporating a mentorship model, a multi-day outdoor wilderness team building adventure, leadership roles, career exploration, and a capstone sustainability action project, all with a focus on educating for sustainability. For those interested in reconnecting with nature and exploring career connections to sustainability, this is the leadership experience for you!

Virtual MSU Tollgate Farm HomeGrown Gardening Series for families and individuals, sponsored by Bordines https://events.anr.msu.edu/msutollgatehomegrowngardening/ [events.anr.msu.edu]February September 2021Are you interested in starting a vegetable garden for the first time or are you an experienced veggie gardener looking to explore new ideas? All levels of experience are welcome at this new series designed to encourage and support home vegetable gardeners! $10 per session for one household, $75 for all eight sessions. Preregistration required.

Second Saturdays, 10 amFeb. 13 - Home Vegetable Gardening 101March 13 - Seed-Starting for EveryoneApril 10 - Vegetable Gardening in Small SpacesMay 8 - Growing Fun with KidsJune 12 - Taking Growing to New HeightsJuly 10 - Season Extension for the Home GardenAug. 14 - Companion PlantingSept. 11 - Veggie Harvest and Storage

Virtual MSU Tollgate Farm Interactive Series for School Teachers and Their Students https://events.anr.msu.edu/TollgateGroupVirtualFarmSeries/ [events.anr.msu.edu]

Follow this link:
Exploring MSU Tollgate virtually is the next best thing to being on the farm - WXYZ

Read More...

Study: CBD use during pregnancy affects the brain, behavior in adulthood – Southernminn.com

January 31st, 2021 2:51 am

The use of cannabidiol (CBD), the major non-psychoactive compound in cannabis, is on the rise across the United States. Pregnant women in particular may view CBD as more natural than other remedies for concerns such as nausea and pain, but the consequences of use for the developing fetus are unknown.

In a new study published in the journal Clinical Epigenetics, researchers at the University of Minnesota used a rodent model to investigate the impact of CBD during development and uncovered effects on the brain and behavior. They found that CBD use during pregnancy may affect mood and cognition in offspring long after the exposure has ceased. The study is the first to examine the effects of maternal CBD exposure during pregnancy on adult offspring in mammals.

The research team, made up of scientists at the University of Minnesotas Department of Animal Science and College of Veterinary Medicine, began by using a human-relevant dose that is typical in adults purchasing CBD over the counter for a variety of ailments. Next, the team treated pregnant mice daily throughout pregnancy and lactation until the pups were weaned. The offspring were followed into adulthood without any additional CBD, at which time they were measured for persistent behavioral and molecular impacts of CBD.

Specifically, the team of scientists investigated rodent behavior and DNA methylation, an important mechanism known as an epigenetic mark in both rodents and humans that helps control the when, where, and how much of gene activity. CBDs effects on gene activity markers were examined in two brain regions important for memory, mood, and cognition.

Among the studys key findings:

Chronic maternal CBD treatment increased anxiety and improved memory performance in adult female offspring, while males were unaffected.

The effects of CBD during pregnancy persisted even though the offspring had no direct exposure as adults.

Maternal CBD treatment shifted gene regulatory marks (DNA methylation) at hundreds of genes in the brains of adult female offspring.

Genes affected by CBD were involved in the formation of new neurons and synapses, communication between neurons, and diseases like autism spectrum disorder, epilepsy and substance use disorder.

CBD use has exploded in recent years, yet we still dont have a clear picture of its impact on the brain, especially during development, said study director Christopher Faulk, an assistant professor in the College of Food, Agricultural and Natural Resource Sciences. We show here that use during pregnancy can permanently impact the resulting offspring in adulthood and potentially for the rest of their lives.

The effects we observed on memory and anxiety were in 12-week-old mouse offspring, a time that approximates human young adulthood, and is cause for concern, said study co-author and project lead Nicole Wanner, a post-doctoral fellow in the College of Veterinary Medicine. DNA methylation marks in the brain are largely set during fetal development, and the presence of CBD during that process appears to direct certain permanent changes. We were surprised at the extent that CBD linked gene pathways were associated with neurological disorders, and expect future work will be needed to understand how fetal exposure to CBD impacts long-term brain function and mental health.

According to Faulk and Wanner, gaining more insight into how CBD affects the developing brain will be important for future safety recommendations.

The researchers are continuing to draw the epigenetic map of gestational CBD exposure and its impact on youth and adults. In the future, they hope to expand behavioral studies to include measures of sociability and drug reward, which are important for diseases like autism spectrum disorder and substance use disorder, respectively. They also plan to repeat these measurements in adolescent offspring in order to determine whether abnormalities are already present at an earlier age or whether they develop later.

Original post:
Study: CBD use during pregnancy affects the brain, behavior in adulthood - Southernminn.com

Read More...

Dominica opens first university in the region to offer only veterinary studies – Dominica News Online

January 31st, 2021 2:51 am

Host of Invited guests government officials and fellow veterinarians at the opening ceremony

On Friday, January 29, 2021, Dominica became the only Caribbean country with a medical school that solely focuses on veterinary studies.

This, according to the President of the St Nicholas University School of Veterinary Studies, Golnaz Naderkhani, MD Ph.D., who spoke during the official opening ceremony at the schools current location on the corner of Hillsborough Street and Kings Lane in Roseau.

Dr. Naderkhani made known that unlike the other medical schools in the region that also provide veterinary medicine education as a side branch, her university is 100% percent focused and dedicated to providing training in that discipline.

St Nicholas university is the first and only academic institution of its kind in the Caribbean, she stated. We are an academic institution committed to providing quality education training.

She said the pillars of her university are quality education, student center training, accessibility and affordability, sustainability, being at the heart of the community, personal learning experience, heritage and tradition, and character and morality.

The Canadian doctor who moved to Dominica following the passage of Hurricane Maria, informed the audience that very soon, Dominica will be the first to boast of having a specialized veterinary hospital capable of providing world-class care, equipped with a radiologist, pathologist, internist, orthopedic surgeon, oncologist, as well as an agro medicine and critical care specialist.

Due to the ongoing Covid-19 pandemic, she explained that students from high-risk countries such as the United States, Canada, and other Caribbean islands were not allowed to begin this semester, but will join in September of this year. Therefore, only ten students -all females- will be part of the very first class of students on February 1.

Dr. Naderkhani emphasized that once the international students are allowed into the university, this will result in new opportunities for many Dominicans.

Minister of Education and Human Resource Development, Hon. Octavia Alfred, who also spoke at the opening ceremony, stated that the opening of the medical school is an important milestone for all stakeholders and this must be celebrated.

For the government and people of Dominica, this presents an avenue to assist our young people who may be seeking advancement in this field to acquire a degree at home while opening up new opportunities for economic activities due to the presence of the university here, she stated.

Alfred stressed that the success or failure of the school will hold important implications for the Government, and pledged their commitment to providing support to growing the institutions reputation so that it may attract a cadre of young professionals eager to increase their skills and knowledge through the acquisition of a sound education in Dominica.

According to her, We need more veterinarians here who can play an essential role in promoting animal welfare.

Adding his voice to the commendations, Former Chief Veterinary Officer Dr. Reginald Thomas noted that there will no longer be a need to import veterinarians into the country from other parts of the world.

He said that the journey to realizing the establishment of the university in Dominica, has not been an easy one and he thanked the President for her steadfastness in achieving this dream and for choosing Dominica.

Continued here:
Dominica opens first university in the region to offer only veterinary studies - Dominica News Online

Read More...

Their Goal: Meat That’s Better Than Meat | Tufts Now – Tufts Now

January 31st, 2021 2:49 am

There are plenty of reasons to want to shift away from eating meat: its better for the planet and certainly better for animals that would otherwise be eaten. But meat is still a big draw, both in the U.S. and increasingly in medium-income countries like China.

At the Tufts School of Engineering, a team of scientists led by Professor David Kaplan is exploring another avenue to feed this trendmeat grown directly from animal cells. It could be the start of an entirely new agricultural industryas humane and green as plant-based meat substitutes, but providing taste, texture, and nutrition that is even closer to the experience of eating real meat.

The technology is already familiar to cell biologistsgrowing and harvesting cells from a single sample of tissue from a live anesthetized animal, but doing it in ways that may help the cells transform into something similar to the muscle tissue people enjoy eating from beef, chicken, and fish, including shrimp and scallops.

Meat from animals contains connective tissue, vascular networks, fat, and other cell types, as well as blood, biological fluids, and a complex mix of proteins and sugars, all of which contribute to the unique taste and texture of the meat. Replicating that structure and content is the technical challenge that the Tufts team is working on using the tools of tissue engineering.

A variety of flavors and textures can be achieved by growing different types of cells together, like skeletal muscle, fat cells and fibroblasts (the most common type of cell in connective tissue), adding nutrients to the surrounding media (the soup in which the cells grow), or using genetic modification to add components that not only introduce flavors, but can modify color or even improve on the nutritional quality of natural meat.

Andrew Stout, a doctoral student in biomedical engineering, has explored adding myoglobin to the cell growth media, for example. Myoglobin, a natural component of muscle, is a protein that carries iron and oxygen, and is associated with the bloody flavor of meat. He found that its addition to the mix helps improve the color of the cell mass, and even enhanced the growth rate of the meat substitute.

Stout has also been working to enhance the nutritional content of cell-based meat. In a recent journal publication, he reported how he had modified muscle cells from cows by genetically adding enzymatic machinery to produce the antioxidants phytoene, lycopene, and beta-carotene, normally found in plants.

Think of it as a way to make cell-based meat more plant-like in the healthy nutritional components it offers. Adding beta-carotene, for example, could have protective effects against colorectal cancer, which tends to be more prevalent among those with a high intake of red meat. Another benefit of this type of metabolic engineering is that the antioxidants could improve the quality and shelf-life of the meat.

How far can they take this nutritional engineering? I think other nutrients would definitely work, said Stout. Thats one of the things that I am the most excited about. Putting plant genes into mammalian cells is pretty un-travelled scientific territory, and so theres a lot of space to explore other nutrients, flavor, and color compounds. In addition, he adds, the cell-based meat can be engineered as a therapeutic food.

Most cell-based approaches have emulated processed meat such as hamburger, sausage, and nuggets. Replicating the appearance and texture of whole cuts of meat, like steak, is a different kind of challenge.

Tissue engineering experts in the Kaplan lab bring a lot of experience to the task of aligning cells and creating fibers resembling real meat structure, using things like mechanical tension and micropatterned substrates to help align cells into fibers.

Natalie Rubio, a Ph.D. student in biomedical engineering, found that switching from cows to caterpillars as a source of cells can have some advantages. The muscle and fat stem cells originating from the eggs of the tobacco hornworma beefy little caterpillarcan be used to generate tissue that resembles other invertebrates that were used to eating, like shrimp and scallops.

A vast amount of knowledge has already developed around large scale invertebrate cell culture, since insect cells are widely used in the production of pharmaceuticals. Suspended in a liquid medium, they tend to grow to very high density and have simpler requirements for maintenance and growth. Yields could be greater and production costs lower than from mammalian cells.

But Rubio explains that there is a very important step remaining to transform a soup of cells into something resembling real meatproviding a scaffold to shape and orient the cells.

The scaffold is the backbone of the meatit provides structure and texture, said Rubio. If we did not have that support structure, the meat would just look like slime.

Rubio generates scaffolds from chitosana polymer found in a closely related form (chitin) in exoskeletons such as crab shells and fungi. Chitosan is a great material to make scaffolds from because it is edible, abundant, and inexpensive, she said.

Chitin can be isolated from fungi and easily converted to chitosan and then formed into films, fibers, or sponges to act as scaffolding for cell culture. Rubio grows insect muscle and fat cells on the chitosan scaffolds to generate small, structured meat constructs.

Kaplans lab has been a hub and catalyst for cellular agriculture research and development in the academic sector for many years, he said. That continues with an annual course for undergraduates on cellular agriculture, which is again being offered this spring semester.

Cell-based meat has not yet been commercialized, but the first cultured beef burger was produced by Maastricht University in 2013, and a number of start-up companies are now working to create new products to sell.

Alumni from our group have fanned out across the globe to help create the foundation of a nascent cell-based agricultural industry, Kaplan said. They include Laura Domigan, who is a principal investigator at University of Auckland; research scientist Amanda Baryshyan at Gloucester Marine Genomics Institute; Ryan Pandya, CEO of Perfect Day Foods; Viktor Maciag, head of tissue engineering at Mission Barns; and Robin Simsa, CEO of Legendary Vish.

Mike Silver can be reached at mike.silver@tufts.edu.

Follow this link:
Their Goal: Meat That's Better Than Meat | Tufts Now - Tufts Now

Read More...

Stem Cell Therapy Market Size to Reach USD 5,040 Million by 2028 | Rising Public-Private Investments and Developing Regulatory Framework for Stem Cell…

January 31st, 2021 2:48 am

Vancouver, British Columbia, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Stem Cell Therapy Market Size to Reach USD 5,040 Million by 2028 | Rising Public-Private Investments and Developing Regulatory Framework for Stem Cell Therapeutics will be the Key Factor Driving the Industry Growth, States Emergen Research

The global stem cell therapy market size was valued at USD 342.7 Million in 2019 and is anticipated to reach USD 3,693.6 Million by 2027 at a CAGR of 36.2%, over the forecast period, according to most recent analysis by Emergen Research.

Growing prevalence of chronic diseases will drive the growth of the stem cell therapy market. Increased investment in research activities, development of advanced genetic techniques, and rise in public-private partnership will contribute to the growth of the stem cell therapy market.

Stem cells are used to improve health and manage disease. The growing popularity of regenerative medicine has encouraged the growth of stem cell therapy market. Regenerative medicines are used to replace, repair, and regenerate tissues affected by disease, injury, and aging process. Regenerative medicines are used in research to find a cure for diabetes, Parkinson's, and Alzheimer's disease.

Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample-form/83

However, ethical concerns regarding embryonic stem cells and less developed research infrastructure will hinder the stem cell therapy market's growth.

Companies Profiled in Stem Cell Therapy Market Research Report:

Virgin Health Bank, Celgene Corporation, ReNeuron Group plc, Biovault Family, Precious Cells International Ltd., Mesoblast Ltd., Opexa Therapeutics, Inc., Caladrius, Neuralstem, Inc., and Pluristem.

Key Highlights of Report

Check Our Prices@ https://www.emergenresearch.com/select-license/83Emergen Research has segmented the global stem cell therapy market in terms of type, application, end-users, and region:

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/stem-cell-therapy-market

Take a Look at our Related Reports:

AI-Enabled Medical Imaging Solutions Market By Product (Software, Hardware), By Workflow (Image Acquisition, Image Analysis, Reporting, and Communication), By Therapeutic Application (General Imaging, Specialty Imaging), By Deployment Mode, By Modality, and By Region, Forecasts to 2027

Patient Registry Software Market By Delivery, By Database, By Registry Type, By Function, By Software Type (Integrated, Standalone), By End-use (Government & Third-Party Administrators, Pharmaceutical Companies, Hospitals, Research Centers, Others), and By Region, Forecast to 2027

Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: http://www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkedIn | Twitter | Blogs

Read Full Press Release@ https://www.emergenresearch.com/press-release/global-stem-cell-therapy-market

The rest is here:
Stem Cell Therapy Market Size to Reach USD 5,040 Million by 2028 | Rising Public-Private Investments and Developing Regulatory Framework for Stem Cell...

Read More...

ProgenCell – Stem Cell Therapies offers an updated Stem Cell Therapy for Anti Aging Protocol – PR Web

January 31st, 2021 2:48 am

SAN DIEGO (PRWEB) January 29, 2021

ProgenCell Stem Cell Therapies announced an updated stem cell therapy for anti aging or healthy aging protocol. A Comprehensive protocol developed by the more than 12 years of experience in the field of Regenerative Medicine and the most rigorous scientific protocols, and overseen by an Independent Review Board (IRB) composed by prominent figures in medicine and scientific research.

The Anti Aging Stem Cell Treatment Protocol is performed administering stem cells intravenously with a previous and strict regimen of multivitamins, minerals and hormones and a subsequent nutritional and vitamin support.

This updated protocol has been developed thanks to the information we have been able to compile, analyze and research, allowing us to determine the dosage of the vitamins. Hormones and nutrients administered according to each patients context, added Dr. Jorge Luis Gavio ProgenCells Medical Director. ProgenCells stem cell research center has an in-house laboratory and adjacent medical facility, which not only sets us apart as an institution, it also gives us the scientific platform to upgrade our protocols, he continued.

To date, ProgenCell Stem Cell Therapies has been offering stem cell therapy in Mexico successfully with a wide range of protocolos designed specifically for many conditions including Parkinsons Disease, Multiple Sclerosis, Retinitis Pigmentosa, and arthritis just to name a few.

Stem cell therapy for anti aging at ProgenCell Stem Cell Therapies is offered by board certified and fully licensed doctors, and every case is overseed by an Independent Review Board, with a scientific and Ethics Committee.

The treatments at ProgenCell Stem Cells comply with quality assurance standards that exceed those recommended by the FDA (Federal Drug Administration), and all protocols are registered and audited by COFEPRIS (the mexican government agency with jurisdiction).

The process of becoming a ProgenCell Patient for Anti Aging Stem Cell Therapy Protocol starts with a free virtual consultation with a Regenerative Medicine Scientific Liaison who will guide you through the process and establish a health route map. After the treatment is booked, a patient concierge works with each international patient on travel logistics, to live the full ProgenCel Experience.

For more information on stem cell therapy for anti aging and to obtain a free consultation, call (888) 443-6235 or visit http://www.progencell.com to learn more.

Share article on social media or email:

See the original post:
ProgenCell - Stem Cell Therapies offers an updated Stem Cell Therapy for Anti Aging Protocol - PR Web

Read More...

Stem Cell Therapy Market 2021: Global Key Players, Trends, Share, Industry Size, Segmentation, Forecast To 2027 KSU | The Sentinel Newspaper – KSU |…

January 31st, 2021 2:48 am

Stem Cell Therapy Market is valued at USD 9.32 Billion in 2018 and expected to reach USD 16.51 Billion by 2025 with the CAGR of 8.5% over the forecast period.

Rising prevalence of chronic diseases, increasing spend on research & development and increasing collaboration between industry and academia driving the growth of stem cell therapy market.

Scope of Stem Cell Therapy Market-

Stem cells therapy also known as regenerative medicine therapy, stem-cell therapy is the use of stem cells to prevent or treat the condition or disease. Stem cell are the special type of cells those differentiated from other type of cell into two defining characteristics including the ability to differentiate into a specialized adult cell type and perpetual self-renewal. Under the appropriate conditions in the body or a laboratory stem cells are capable to build every tissue called daughter cells in the human body; hence these cells have great potential for future therapeutic uses in tissue regeneration and repair. Among stem cell pluripotent are the type of cell that can become any cell in the adult body, and multipotent type of cell are restricted to becoming a more limited population of cells.

Get Sample of This Report@ https://brandessenceresearch.com/requestSample/PostId/1246

The stem cell therapy has been used to treat people with conditions including leukemia and lymphoma, however this is the only form of stem-cell therapy which is widely practiced. Prochymal are another stem-cell therapy was conditionally approved in Canada in 2012 for the treatment of acute graft-vs-host disease in children those are not responding to steroids. Nevertheless, hematopoietic stem cell transplantation is the only established therapy using stem cells. This therapy involves the bone marrow transplantation.

Stem cell therapy market report is segmented based on type, therapeutic application, cell source and by regional & country level. Based upon type, stem cell therapy market is classified into allogeneic stem cell therapy market and autologous market.

Stem Cell Therapy Companies:

Stem cell therapy market report covers prominent players like,

Based upon therapeutic application, stem cell therapy market is classified into musculoskeletal disorders, wounds and injuries, cardiovascular diseases, surgeries, gastrointestinal diseases and other applications. Based upon cell source, stem cell therapy market is classified into adipose tissue-derived mesenchymal stem cells, bone marrow-derived mesenchymal stem cells, cord blood/embryonic stem cells and other cell sources

The regions covered in this stem cell therapy market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of stem cell therapy is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Stem Cell Therapy Market Segmentation

By Type

Allogeneic Stem Cell Therapy Market, By Application

Autologous Market, By Application

By Therapeutic Application

By Cell Source

Stem Cell Therapy Market Dynamics

Rising spend on research and development activities in the research institutes and biotech industries driving the growth of the stem cell therapy market during the forecast period. For instance, in January 2010, U. S. based Augusta University initiated Phase I clinical trial to evaluate the safety and effectiveness of a single, autologous cord blood stem infusion for treatment of cerebral palsy in children. The study is estimated to complete in July 2020. Additionally, increasing prevalence of chronic diseases creating the demand of stem cell therapy. For instance, as per the international diabetes federation, in 2019, around 463 million population across the world were living with diabetes; by 2045 it is expected to rise around 700 million. Among all 79% of population with diabetes were living in low- and middle-income countries. These all factors are fuelling the growth of market over the forecast period. On the other flip, probabilities of getting success is less in the therapeutics by stem cell may restrain the growth of market. Nevertheless, Advancement of technologies and government initiative to encourage research in stem cell therapy expected to create lucrative opportunity in stem cell therapy market over the forecast period.

Stem Cell Therapy Market Regional Analysis

North America is dominating the stem cell therapy market due increasing adoption rate of novel stem cell therapies fueling the growth of market in the region. Additionally, favorable government initiatives have encouraging the regional market growth. For instance, government of Canada has initiated Strategic Innovation Fund Program, in which gov will invests in research activities carried out for stem cell therapies. In addition, good reimbursing scheme in the region helping patient to spend more on health. Above mentioned factors are expected to drive the North America over the forecast period.

Full Research Report @ https://brandessenceresearch.com/healthcare/stem-cell-therapy-market-size

About us: Brandessence Market Research and Consulting Pvt. Ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals, and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations, and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact usat: +44-2038074155 ormail usatsales@brandessenceresearch.com

Website: https://brandessenceresearch.com/

Article: https://businessstatsnews.com

Blog: https://technologyindustrynews.com

Blog: https://marketstatsreport.com

Blog: https://industrywatchnews.com/

See original here:
Stem Cell Therapy Market 2021: Global Key Players, Trends, Share, Industry Size, Segmentation, Forecast To 2027 KSU | The Sentinel Newspaper - KSU |...

Read More...

ClearPoint Neuro, Inc. Announces Expansion of Pre-Clinical and Translational Development Team to Support Gene and Stem Cell Therapy Partners -…

January 31st, 2021 2:48 am

IRVINE, Calif., Jan. 26, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that Ernesto Salegio, PhD will join the Company as Vice President, Segment Leader Translational and Pre-Clinical Research as part of ClearPoints Biologics and Drug Delivery team on March 1, 2021. Dr. Salegio brings over 19 years of experience in translational neuroscience with direct pre-clinical central nervous system (CNS) expertise in the delivery of therapeutics to the brain and spinal cord, including over 16 years of gene therapy experience working with adeno-associated viral vectors (AAV).

ClearPoint Neuros Biologics and Drug Delivery team was established in 2020 to provide turn-key medical device innovation, therapy delivery development and clinical services customized for both pharmaceutical and academic partners working on gene and stem cell therapies to the brain. This team also offers comprehensive services to help its partners navigate existing regulatory guidance and stay abreast of anticipated changes to guidance that will inevitably come.

Our current and prospective partners working on gene and stem cell therapies have an enormous unmet need for pre-clinical support, commented Jeremy Stigall, Vice President, Biologics & Drug Delivery Development. Ernestos extensive pre-clinical expertise in the intraparenchymal administration of therapeutics under image-guidance, as well into cerebrospinal fluid (CSF), will allow ClearPoint to add crucial translational consulting services for our biologics partners. When we establish relationships with pharmaceutical partners well before the clinic, ClearPoint products and services can be incorporated throughout the entire development process, delivering consistent, predictable performance, and providing government agencies assurance that the navigation and delivery platform will remain constant from bench-to-bedside. We aim to become their comprehensive medical device partner, allowing them to focus on more traditional pharmaceutical challenges, while ClearPoint delivers state-of-the-art medical device and therapy delivery.

I am thrilled to become a member of the ClearPoint team, commented Dr. Salegio. After spending almost two decades focusing on translational research, image-guided delivery protocols, complex surgical procedures and in the development of CNS therapies, I am delighted to drive the expansion of ClearPoints capabilities. I am eager to leverage their current pre-clinical and clinical portfolio, as well as to their pipeline of innovative tools on the horizon, to provide customized solutions to current and future ClearPoint pharmaceutical partners.

About ClearPoint Neuro

ClearPoint Neuros mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy. Applications of the Companys current product portfolio include deep-brain stimulation, laser ablation, biopsy, neuro-aspiration, and delivery of drugs, biologics, and gene therapy to the brain. The ClearPoint Neuro Navigation System has FDA clearance, is CE-marked, and is installed in over 60 active clinical sites in the United States and the EU. The Companys SmartFlow cannula is being used in partnership or evaluation with 25 individual biologics and drug delivery companies in various stages from preclinical research to late-stage regulatory trials. To date, more than 4,000 cases have been performed and supported by the Companys field-based clinical specialist team which offers support and services for our partners. For more information, please visit http://www.clearpointneuro.com.

Forward-Looking Statements

Statements herein concerning the Companys plans, growth and strategies may include forward-looking statements within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. Uncertainties and risks may cause the Company's actual results to differ materially from those expressed in or implied by forward-looking statements. Particular uncertainties and risks include those relating to the impact of COVID-19 and the measures adopted to contain its spread; future revenues from sales of the Companys ClearPoint Neuro Navigation System products; the Companys ability to market, commercialize and achieve broader market acceptance for the Companys ClearPoint Neuro Navigation System products; and estimates regarding the sufficiency of the Companys cash resources. More detailed information on these and additional factors that could affect the Companys actual results are described in the Risk Factors section of the Companys Annual Report on Form 10-K for the year ended December 31, 2019, and the Companys Quarterly Report on Form 10-Q for the three months ended September 30, 2020, both of which have been filed with the Securities and Exchange Commission, and the Companys Annual Report on Form 10-K for the year ended December 31 2020, which the Company intends to file with the Securities and Exchange Commission on or before March 31, 2021.

Visit link:
ClearPoint Neuro, Inc. Announces Expansion of Pre-Clinical and Translational Development Team to Support Gene and Stem Cell Therapy Partners -...

Read More...

Stem Cell Therapy for Diabetes and Related Conditions Market Size |Incredible Possibilities and Growth Analysis and Forecast To 2025 – AlgosOnline

January 31st, 2021 2:48 am

Global Stem Cell Therapy for Diabetes and Related Conditions Market Report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and challenges.

The research document on Stem Cell Therapy for Diabetes and Related Conditions market comprises of key trends that define the industry growth in terms of the regional landscape and competitive outlook. It highlights the limitations & restraints as well as the growth avenues impacting the overall market dynamics. Apart from this, the report provides with significant information regarding the effect of Coronavirus pandemic on the industry remuneration.

Request a sample Report of Stem Cell Therapy for Diabetes and Related Conditions Market at:https://www.marketstudyreport.com/request-a-sample/3159653?utm_source=algos&utm_medium=Pravin

Key insights from COVID-19 impact analysis:

An overview of the regional landscape:

Additional information from the Stem Cell Therapy for Diabetes and Related Conditions market report:

Ask for Discount on Stem Cell Therapy for Diabetes and Related Conditions Market Report at:https://www.marketstudyreport.com/check-for-discount/3159653?utm_source=algos&utm_medium=Pravin

Comprehensive assessment of all opportunities and risks in the Stem Cell Therapy for Diabetes and Related Conditions market.

This exclusive study addresses key questions for stakeholders in the Stem Cell Therapy for Diabetes and Related Conditions Market:

For More Details On this Report: https://www.marketstudyreport.com/reports/global-stem-cell-therapy-for-diabetes-and-related-conditions-market-research-report-with-opportunities-and-strategies-to-boost-growth-covid-19-impact-and-recovery

Some of the Major Highlights of TOC covers:

Stem Cell Therapy for Diabetes and Related Conditions Regional Market Analysis

Stem Cell Therapy for Diabetes and Related Conditions Segment Market Analysis (by Type)

Stem Cell Therapy for Diabetes and Related Conditions Segment Market Analysis (by Application)

Stem Cell Therapy for Diabetes and Related Conditions Major Manufacturers Analysis

Read More Related Reports at: https://www.marketwatch.com/press-release/Latest-report-on-Hydrocephalus-Shunts-Market-size-with-growing-CAGR-of-72-by-2025-2021-01-25

Contact Us:Corporate Sales,Market Study Report LLCPhone: 1-302-273-0910Toll Free: 1-866-764-2150 Email: [emailprotected]

More:
Stem Cell Therapy for Diabetes and Related Conditions Market Size |Incredible Possibilities and Growth Analysis and Forecast To 2025 - AlgosOnline

Read More...

Page 262«..1020..261262263264..270280..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick